What is RSV Immunisation for Babies?

RSV immunisation, using a monoclonal antibody called nirsevimab, protects newborns and young babies against severe illness from respiratory syncytial virus (RSV), a common cause of serious lung infections in the first months of life. The immunisation starts working immediately and protects for around 150 days, covering the period when babies are most vulnerable.

In Ireland, the programme offers immunisation to all babies born in maternity hospitals during the RSV season (typically September to February), given before discharge home, as well as to babies aged 6 months or younger at the start of the season through a community catch-up programme. It follows a highly successful first year, during which cases, hospitalisations, and ICU admissions among immunised babies all fell dramatically compared with previous years.